Literature DB >> 23415574

Ultra-LAMA, ultra-LABA, ultra-inhaled steroids? The future has landed.

Christian Domingo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23415574     DOI: 10.1016/j.arbres.2012.11.011

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN: 0300-2896            Impact factor:   4.872


× No keyword cloud information.
  4 in total

1.  Comparison of clinical efficacy between ultra-LABAs and ultra-LAMAs in COPD: a systemic review with meta-analysis of randomized controlled trials.

Authors:  Eun Yeong Cho; Se Yong Kim; Min-Ji Kim; Seonwoo Kim; Dong Ah Park; Kwang Ha Yoo; Yong Bum Park; Yong Il Hwang; Chin Kook Rhee; Ji Ye Jung; Hyun Lee; Hye Yun Park
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

Review 2.  Omalizumab for severe asthma: efficacy beyond the atopic patient?

Authors:  Christian Domingo
Journal:  Drugs       Date:  2014-04       Impact factor: 9.546

Review 3.  Tailoring of corticosteroids in COPD management.

Authors:  Daan A De Coster; Melvyn Jones
Journal:  Curr Respir Care Rep       Date:  2014-07-06

4.  Efficacy and safety of twice-daily glycopyrrolate in patients with stable, symptomatic COPD with moderate-to-severe airflow limitation: the GEM1 study.

Authors:  Craig LaForce; Gregory Feldman; Selwyn Spangenthal; Joerg H Eckert; Michelle Henley; Francesco Patalano; Peter D'Andrea
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-06-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.